Cyclophosphamide Loading and Controlled Release in MIL-100(Fe) as an Anti-Breast Cancer Carrier: In vivo in vitro Study.

Shabnam TohidiMehrdad Aghaie-Khafri

Published in: Current drug delivery (2023)

In vivo antitumor experiments and histological observation reveal inhibition properties of MIL-100(Fe)/CP on the tumor cells. MIL-100(Fe)/CP, with 37.41% drug payload, represents impressive antitumor activity.

Keyphrases

metal organic framework
solid phase extraction
high dose
low dose
emergency department
dna methylation
gene expression
young adults
simultaneous determination